Top

Published in:

Open Access 01-08-2019 | Metastasis | Original Paper

Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis

Authors: Jin Jin, Shi-Jie Wang, Jian Cui, Ling Li, Jia-Yue Li, Fen-Ling Liu, Xiu-Xuan Sun, Jian-Li Jiang, Hong-Yong Cui, Zhi-Nan Chen

Published in: Cellular Oncology | Issue 4/2019

Abstract

Purpose

CD147 is a tumor-associated antigen that plays a key regulatory role in tumor invasion and distant metastasis. However, the exact role of CD147 phosphorylation, which is deregulated during cancer progression, is unknown. Here, the effects of CD147 phosphorylation on the malignant behavior of hepatocellular carcinoma (HCC) cells and its possible underlying mechanisms are explored.

Methods

An in situ Duolink-proximity ligation assay (PLA) was used to detect CD147 phosphorylation. Tandem mass spectrometry was employed to identify the phosphorylation sites of CD147. The effects of CD147 phosphorylation on the malignant behavior of HCC cells were evaluated using scratch wound healing assays, transwell invasion assays and cell cycle assays. The genes regulated by CD147 phosphorylation were detected by RNA sequencing.

Results

We identified phosphorylated serine-246 in the C terminus of CD147 in primary HCC tissues, whereas serine to alanine substitution mutation analysis suggested that CD147 is phosphorylated mainly at serine-252 in HCC-derived Huh-7 cells. Recovery expression of S246A/S252A mutants in CD147 knockout cells revealed significantly increased migration and invasion capacities compared to wildtype CD147 expressing cells. Cyclophilin A (CyPA) treatment decreased the phosphorylation level of CD147, whereas NIMA-related kinase 6 (NEK6) increased the CD147 phosphorylation level. Moreover, the CD147 phosphorylation level was found to be dramatically decreased in HCC tissues in patients with distant metastases, and a low phosphorylation level of CD147 was found to be associated with a high serum AFP level, recurrence and a poor overall survival.

Conclusions

From our data we conclude that hypo-phosphorylated CD147 promotes the migration and invasion of HCC cells and correlates with an unfavorable prognosis in HCC patients, indicating that targeting the aberrantly hypo-phosphorylated form of CD147 may be instrumental for the development of novel therapeutic modalities directed against HCC metastasis.

Available only for authorised users

L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, A. Jemal, Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108 (2015)CrossRef

M. Yilmaz, G. Christofori, Mechanisms of motility in metastasizing cells. Mol Cancer Res 8, 629–642 (2010)CrossRef

O. Karaosmanoglu, S. Banerjee, H. Sivas, Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells. Cell Oncol 41, 439–453 (2018)

R. D'Alessandro, M.G. Refolo, C. Lippolis, N. Carella, C. Messa, A. CavalliniB, I. Carr, Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1. Cell Oncol 41, 283–296 (2018)

S. ValastyanR, A. Weinberg, Tumor metastasis: Molecular insights and evolving paradigms. Cell 147, 275–292 (2011)CrossRef

H. Wang, L. Chen, Tumor microenviroment and hepatocellular carcinoma metastasis. J Gastroenterol Hepatol 28(Suppl 1), 43–48 (2013)CrossRefPubMed

Y.L. Jia, L. Shi, J.N. Zhou, C.J. Fu, L. Chen, H.F. Yuan, Y.F. Wang, X.L. Yan, Y.C. Xu, Q. Zeng, W. Yue, X.T. Pei, Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis. Hepatology 54, 1808–1818 (2011)CrossRefPubMed

Z.Y. Tang, S.L. Ye, Y.K. Liu, L.X. Qin, H.C. Sun, Q.H. Ye, L. Wang, J. Zhou, S.J. Qiu, Y. Li, X.N. Ji, H. Liu, J.L. Xia, Z.Q. Wu, J. Fan, Z.C. Ma, X.D. Zhou, Z.Y. Lin, K.D. Liu, A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 130, 187–196 (2004)CrossRefPubMed

Z.Y. Tang, Hepatocellular carcinoma surgery--review of the past and prospects for the 21st century. J Surg Oncol 91, 95–96 (2005)CrossRefPubMed

10.

T. Muramatsu, Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners. J Biochem 159, 481–490 (2016)CrossRefPubMed

11.

T. Kanekura, X. Chen, CD147/basigin promotes progression of malignant melanoma and other cancers. J Dermatol Sci 57, 149–154 (2010)CrossRefPubMed

12.

P. Zhao, W. Zhang, S.J. Wang, X.L. Yu, J. Tang, W. Huang, Y. Li, H.Y. Cui, Y.S. Guo, J. Tavernier, S.H. Zhang, J.L. Jiang, Z.N. Chen, HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells. Hepatology 54, 2012–2024 (2011)CrossRefPubMed

13.

S.J. Wang, H.Y. Cui, Y.M. Liu, P. Zhao, Y. Zhang, Z.G. Fu, Z.N. ChenJ, L. Jiang, CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells. Oncotarget 6, 243–257 (2015)PubMed

14.

H.Y. Cui, S.J. Wang, J.Y. Miao, Z.G. Fu, F. Feng, J. Wu, X.M. Yang, Z.N. ChenJ, L. Jiang, CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-beta-catenin-WAVE2 signaling. Oncotarget 7, 5613–5629 (2016)PubMed

15.

P. Zhao, W. Zhang, J. Tang, X.K. Ma, J.Y. Dai, Y. Li, J.L. Jiang, S.H. Zhang, Z.N. Chen, Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 101, 387–395 (2010)CrossRefPubMed

16.

L.M. Kong, C.G. Liao, Y. Zhang, J. Xu, Y. Li, W. Huang, Y. Zhang, H. BianZ, N. Chen, A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis. Cancer Res 74, 3764–3778 (2014)CrossRefPubMed

17.

H. Voigt, C.S. Vetter-Kauczok, D. Schrama, U.B. Hofmann, J.C. Becker, R. Houben, CD147 impacts angiogenesis and metastasis formation. Cancer Investig 27, 329–333 (2009)CrossRef

18.

A. Lee, A. Rode, A. Nicoll, A.E. Maczurek, L. Lim, S. Lim, P. Angus, I. Kronborg, N. Arachchi, A. Gorelik, D. Liew, F.J. Warner, G.W. McCaughan, S.V. McLennan, N.A. Shackel, Circulating CD147 predicts mortality in advanced hepatocellular carcinoma. J Gastroenterol Hepatol 31, 459–466 (2016)CrossRefPubMed

19.

S. Zhu, Y. Li, Y. Zhang, X. Wang, L. Gong, X. Han, L. Yao, M. Lan, W. Zhang, Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma. Hepatol Res 45, 97–106 (2015)CrossRefPubMed

20.

G.D. GrassB, P. Toole, How, with whom and when: An overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Biosci Rep 36, e283 (2015)

21.

J. Wu, N.Y. Ru, Y. Zhang, Y. Li, D. Wei, Z. Ren, X.F. Huang, Z.N. Chen, H. Bian, HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-beta signaling and is transcriptionally regulated by slug. Oncogene 30, 4410–4427 (2011)CrossRefPubMed

22.

G.D. Grass, M. BratoevaB, P. Toole, Regulation of invadopodia formation and activity by CD147. J Cell Sci 125, 777–788 (2012)CrossRefPubMedPubMedCentral

23.

D. Zhu, Z. Wang, J.J. Zhao, T. Calimeri, J. Meng, T. Hideshima, M. Fulciniti, Y. Kang, S.B. Ficarro, Y.T. Tai, Z. Hunter, D. McMilin, H. Tong, C.S. Mitsiades, C.J. Wu, S.P. Treon, D.M. Dorfman, G. Pinkus, N.C. Munshi, P. Tassone, J.A. Marto, K.C. Anderson, R.D. Carrasco, The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat Med 21, 572–580 (2015)CrossRefPubMedPubMedCentral

24.

W. Huang, W.J. Luo, P. Zhu, J. Tang, X.L. Yu, H.Y. Cui, B. Wang, Y. Zhang, J.L. Jiang, Z.N. Chen, Modulation of CD147-induced matrix metalloproteinase activity: Role of CD147 N-glycosylation. Biochem J 449, 437–448 (2013)CrossRefPubMed

25.

X. Zhao, I.R. Leon, S. Bak, M. Mogensen, K. Wrzesinski, K. Hojlund, O.N. Jensen, Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes. Mol Cell Proteomics 10, M110–M299 (2011)PubMedPubMedCentral

26.

G. Han, M. Ye, H. Liu, C. Song, D. Sun, Y. Wu, X. Jiang, R. Chen, C. Wang, L. Wang, H. Zou, Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis 31, 1080–1089 (2010)PubMed

27.

Y. Bian, C. Song, K. Cheng, M. Dong, F. Wang, J. Huang, D. Sun, L. Wang, M. Ye, H. Zou, An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteome 96, 253–262 (2014)CrossRef

28.

D. Rolland, V. Basrur, K. Conlon, T. Wolfe, D. Fermin, A.I. Nesvizhskii, M.S. LimK, S. Elenitoba-Johnson, Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas. Am J Pathol 184, 1331–1342 (2014)CrossRefPubMedPubMedCentral

29.

Y.T. Wang, C.F. Tsai, T.C. Hong, C.C. Tsou, P.Y. Lin, S.H. Pan, T.M. Hong, P.C. Yang, T.Y. Sung, W.L. Hsu, Y.J. Chen, An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion. J Proteome Res 9, 5582–5597 (2010)CrossRefPubMed

30.

S.G. Kwon, J.H. Hwang, D.H. Park, T.W. Kim, D.G. Kang, K.H. Kang, I.S. Kim, H.C. Park, C.S. Na, J. Ha, C.W. Kim, Identification of differentially expressed genes associated with litter size in Berkshire pig placenta. PLoS One 11, e153311 (2016)

31.

L. Liu, L. Si, X. Meng, L. Luo, Comparative transcriptomic analysis reveals novel genes and regulatory mechanisms of Tetragenococcus halophilus in response to salt stress. J Ind Microbiol Biotechnol 42, 601–616 (2015)CrossRefPubMed

32.

C. Trapnell, D.G. Hendrickson, M. Sauvageau, L. Goff, J.L. Rinn, L. Pachter, Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 31, 46–53 (2013)CrossRef

33.

R. Hong, E. Roberts, C. Bieniarz, In situ detection of protein complexes and modifications by chemical ligation proximity assay. Bioconjug Chem 27, 1690–1696 (2016)

34.

L. Elfineh, C. Classon, A. Asplund, U. Pettersson, M. Kamali-Moghaddam, S.B. Lind, Tyrosine phosphorylation profiling via in situ proximity ligation assay. BMC Cancer 14, 435 (2014)CrossRefPubMedPubMedCentral

35.

L. Li, W. Tang, X. Wu, D. Karnak, X. Meng, R. Thompson, X. Hao, Y. Li, X.T. Qiao, J. Lin, J. Fuchs, D.M. Simeone, Z.N. Chen, T.S. Lawrence, L. Xu, HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Clin Cancer Res 19, 6703–6715 (2013)CrossRefPubMed

36.

S.J. Wang, H.Y. Cui, Y.M. Liu, P. Zhao, Y. Zhang, Z.G. Fu, Z.N. Chen, J.L. Jiang, CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells. Oncotarget 6, 243–257 (2015)PubMed

37.

F. Fei, X. Li, L. Xu, D. Li, Z. Zhang, X. Guo, H. Yang, Z. Chen, J. Xing, CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway. Ann Surg Oncol 21, 4359–4368 (2014)CrossRefPubMed

38.

Y. Tang, M.T. Nakada, P. Rafferty, J. Laraio, F.L. McCabe, H. Millar, M. Cunningham, L.A. Snyder, P. Bugelski, L. Yan, Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Mol Cancer Res 4, 371–377 (2006)CrossRefPubMed

39.

Y. Omi, N. Shibata, T. Okamoto, T. Obara, M. Kobayashi, The role of CD147 in the invasiveness of follicular thyroid carcinoma cells. Thyroid 22, 383–394 (2012)CrossRefPubMed

40.

J.M. Lizcano, M. Deak, N. Morrice, A. Kieloch, C.J. Hastie, L. Dong, M. Schutkowski, U. Reimer, D.R. Alessi, Molecular basis for the substrate specificity of NIMA-related kinase-6 (NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 protein kinase and serum- and glucocorticoid-induced protein kinase in vivo. J Biol Chem 277, 27839–27849 (2002)CrossRefPubMed

41.

Y. Hirai, M. Tamura, J. Otani, F. Ishikawa, NEK6-mediated phosphorylation of human TPP1 regulates telomere length through telomerase recruitment. Genes Cells 21, 874–889 (2016)CrossRefPubMed

42.

K. Arora, W.M. Gwinn, M.A. Bower, A. Watson, I. Okwumabua, H.R. MacDonald, M.I. Bukrinsky, S.L. Constant, Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 175, 517–522 (2005)CrossRefPubMedPubMedCentral

43.

V. Yurchenko, G. Zybarth, M. O'Connor, W.W. Dai, G. Franchin, T. Hao, H. Guo, H.C. Hung, B. Toole, P. Gallay, B. Sherry, M. Bukrinsky, Active site residues of cyclophilin a are crucial for its signaling activity via CD147. J Biol Chem 277, 22959–22965 (2002)CrossRefPubMed

44.

F. Song, X. Zhang, X.B. Ren, P. Zhu, J. Xu, L. Wang, Y.F. Li, N. Zhong, Q. Ru, D.W. Zhang, J.L. Jiang, B. Xia, Z.N. Chen, Cyclophilin a (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: Direct binding between CyPA and the ectodomain of CD147. J Biol Chem 286, 8197–8203 (2011)CrossRefPubMedPubMedCentral

45.

M. Li, Q. Zhai, U. Bharadwaj, H. Wang, F. Li, W.E. Fisher, C. Chen, Q. Yao, Cyclophilin a is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 106, 2284–2294 (2006)CrossRef

46.

K. Sharma, R.C. D'Souza, S. Tyanova, C. Schaab, J.R. Wisniewski, J. Cox, M. Mann, Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583–1594 (2014)CrossRefPubMed

47.

48.

J.H. Li, W. Huang, P. Lin, B. Wu, Z.G. Fu, H.M. Shen, L. Jing, Z.Y. Liu, Y. Zhou, Y. Meng, B.Q. Xu, Z.N. Chen, J.L. Jiang, N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: Promoting tumour metastasis in hepatocellular carcinoma. Sci Rep 6, 35210 (2016)CrossRefPubMedPubMedCentral

49.

F. Berditchevski, S. Chang, J. Bodorova, M.E. Hemler, Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6. J Biol Chem 272, 29174–29180 (1997)CrossRefPubMed

50.

Y. Li, J. Wu, F. Song, J. Tang, S.J. Wang, X.L. Yu, Z.N. ChenJ, L. Jiang, Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin beta1 to modulate malignant properties of hepatoma cells. J Biol Chem 287, 4759–4772 (2012)CrossRefPubMed

51.

52.

D. Xu, M.E. Hemler, Metabolic activation-related CD147-CD98 complex. Mol Cell Proteomics 4, 1061–1071 (2005)CrossRefPubMedPubMedCentral

53.

J.L. Jiang, H.C. Chan, Q. Zhou, M.K. Yu, X.Y. Yao, S.Y. Lam, H. Zhu, L.S. Ho, K.M. Leung, Z.N. Chen, HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domains. Cell Mol Life Sci 61, 2083–2091 (2004)CrossRefPubMed

54.

C. Belham, J. Roig, J.A. Caldwell, Y. Aoyama, B.E. Kemp, M. Comb, J. Avruch, A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases. J Biol Chem 278, 34897–34909 (2003)CrossRefPubMed

55.

M.J. Yin, L. Shao, D. Voehringer, T. Smeal, B. Jallal, The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis. J Biol Chem 278, 52454–52460 (2003)CrossRefPubMed

56.

A.M. Fry, L. O'Regan, S.R. Sabir, R. Bayliss, Cell cycle regulation by the NEK family of protein kinases. J Cell Sci 125, 4423–4433 (2012)CrossRefPubMedPubMedCentral

Title: Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis
Authors: Jin Jin
Shi-Jie Wang
Jian Cui
Ling Li
Jia-Yue Li
Fen-Ling Liu
Xiu-Xuan Sun
Jian-Li Jiang
Hong-Yong Cui
Zhi-Nan Chen
Publication date: 01-08-2019
Publisher: Springer Netherlands
Keywords: Metastasis
Hepatocellular Carcinoma
Hepatocellular Carcinoma
Published in: Cellular Oncology / Issue 4/2019
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI: https://doi.org/10.1007/s13402-019-00444-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2019

The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells

Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition

Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report

Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells

Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells

The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer